308 related articles for article (PubMed ID: 36494182)
1. Carrier-Free H
Yang T; Zhou M; Gao M; Qin W; Wang Q; Peng H; Yao W; Qiao L; He X
Small; 2023 Feb; 19(7):e2205692. PubMed ID: 36494182
[TBL] [Abstract][Full Text] [Related]
2. Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy.
Fu LH; Wan Y; Qi C; He J; Li C; Yang C; Xu H; Lin J; Huang P
Adv Mater; 2021 Feb; 33(7):e2006892. PubMed ID: 33394515
[TBL] [Abstract][Full Text] [Related]
3. H
Xiao Z; Zuo W; Chen L; Wu L; Liu N; Liu J; Jin Q; Zhao Y; Zhu X
ACS Appl Mater Interfaces; 2021 Sep; 13(37):43925-43936. PubMed ID: 34499485
[TBL] [Abstract][Full Text] [Related]
4. Cu-MOF chemodynamic nanoplatform via modulating glutathione and H
Tian H; Zhang M; Jin G; Jiang Y; Luan Y
J Colloid Interface Sci; 2021 Apr; 587():358-366. PubMed ID: 33360905
[TBL] [Abstract][Full Text] [Related]
5. Copper-based theranostic nanocatalysts for synergetic photothermal-chemodynamic therapy.
Zuo W; Fan Z; Chen L; Liu J; Wan Z; Xiao Z; Chen W; Wu L; Chen D; Zhu X
Acta Biomater; 2022 Jul; 147():258-269. PubMed ID: 35605954
[TBL] [Abstract][Full Text] [Related]
6. NIR Responsive Doxorubicin-Loaded Hollow Copper Ferrite @ Polydopamine for Synergistic Chemodynamic/Photothermal/Chemo-Therapy.
Chu X; Zhang L; Li Y; He Y; Zhang Y; Du C
Small; 2023 Feb; 19(7):e2205414. PubMed ID: 36504423
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Specific Expansion of Oxidative Stress by Glutathione Depletion and Use of a Fenton Nanoagent for Enhanced Chemodynamic Therapy.
Chen Q; Zhou J; Chen Z; Luo Q; Xu J; Song G
ACS Appl Mater Interfaces; 2019 Aug; 11(34):30551-30565. PubMed ID: 31397998
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional CuFe
Chen N; Li Y; Li H; Wang Y; Zeng Y; Zhang M; Pan Z; Chen Z; Liang W; Huang J; Zhang K; Liu X; He Y
Colloids Surf B Biointerfaces; 2023 Sep; 229():113445. PubMed ID: 37441838
[TBL] [Abstract][Full Text] [Related]
9. H
Tang Z; Jiang S; Tang W; He Q; Wei H; Jin C; Wang S; Zhang H
Mol Pharm; 2023 Mar; 20(3):1717-1728. PubMed ID: 36809003
[TBL] [Abstract][Full Text] [Related]
10. Dual-responsive and NIR-driven free radical nanoamplifier with glutathione depletion for enhanced tumor-specific photothermal/thermodynamic/chemodynamic synergistic Therapy.
Chen F; Zhang X; Wang Z; Xu C; Hu J; Liu L; Zhou J; Sun B
Biomater Sci; 2022 Oct; 10(20):5912-5924. PubMed ID: 36040793
[TBL] [Abstract][Full Text] [Related]
11. A hollow Co
Jiang Y; Lu H; Yuan X; Zhang Y; Lei L; Li Y; Sun W; Liu J; Scherman D; Liu Y
J Mater Chem B; 2022 Oct; 10(39):8082-8093. PubMed ID: 36128978
[TBL] [Abstract][Full Text] [Related]
12. Amorphous Ultra-Small Fe-Based Nanocluster Engineered and ICG Loaded Organo-Mesoporous Silica for GSH Depletion and Photothermal-Chemodynamic Synergistic Therapy.
Li J; Tian H; Zhu F; Jiang S; He M; Li Y; Luo Q; Sun W; Liu X; Wang P
Adv Healthc Mater; 2022 Nov; 11(21):e2201986. PubMed ID: 36106722
[TBL] [Abstract][Full Text] [Related]
13. Glutathione/pH-responsive copper-based nanoplatform for amplified chemodynamic therapy through synergistic cycling regeneration of reactive oxygen species and dual glutathione depletion.
Jia S; Ke S; Tu L; Chen S; Luo B; Xiong Y; Li Y; Wang P; Ye S
J Colloid Interface Sci; 2023 Dec; 652(Pt A):329-340. PubMed ID: 37597414
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Chemodynamic Therapy Mediated by a Tumor-Specific Catalyst in Synergy with Mitophagy Inhibition Improves the Efficacy for Endometrial Cancer.
Gong X; Wang J; Yang L; Li L; Gao X; Sun X; Bai J; Liu J; Pu X; Wang Y
Small; 2023 Aug; 19(33):e2301497. PubMed ID: 37086131
[TBL] [Abstract][Full Text] [Related]
15. Dual H
Zheng Z; Chen X; Ma Y; Dai R; Wu S; Wang T; Xing J; Gao J; Zhang R
Small; 2022 Sep; 18(37):e2203531. PubMed ID: 35962758
[TBL] [Abstract][Full Text] [Related]
16. Engineering H
Dirersa WB; Kan TC; Chang J; Getachew G; Ochirbat S; Kizhepat S; Wibrianto A; Rasal A; Chen HA; Ghule AV; Chou TH; Chang JY
ACS Appl Mater Interfaces; 2024 May; 16(19):24172-24190. PubMed ID: 38688027
[TBL] [Abstract][Full Text] [Related]
17. Fusiform-Like Copper(II)-Based Metal-Organic Framework through Relief Hypoxia and GSH-Depletion Co-Enhanced Starvation and Chemodynamic Synergetic Cancer Therapy.
Wang Z; Liu B; Sun Q; Dong S; Kuang Y; Dong Y; He F; Gai S; Yang P
ACS Appl Mater Interfaces; 2020 Apr; 12(15):17254-17267. PubMed ID: 32227859
[TBL] [Abstract][Full Text] [Related]
18. Nanocatalyst-Mediated Chemodynamic Tumor Therapy.
Zhang L; Li CX; Wan SS; Zhang XZ
Adv Healthc Mater; 2022 Jan; 11(2):e2101971. PubMed ID: 34751505
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu
Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z
Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045
[TBL] [Abstract][Full Text] [Related]
20. Copperphosphotungstate Doped Polyanilines Nanorods for GSH-Depletion Enhanced Chemodynamic/NIR-II Photothermal Synergistic Therapy.
Ye S; Xiao H; Chen J; Zhang D; Qi L; Peng T; Gao Y; Zhang Q; Qu J; Wang L; Liu R
Int J Nanomedicine; 2023; 18():1245-1257. PubMed ID: 36937549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
